AI-assisted, human-published
05/11/2026 /Funding Events
Anagram Therapeutics Receives $250 Million Investment to Advance Novel Therapy
Anagram Therapeutics secures funding to advance ANG003 for exocrine pancreatic insufficiency due to cystic fibrosis, potentially reducing daily pill burden and introducing a non-porcine extract product.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com